drugset / Trial / NCT03347266

Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injection for Postoperative Pain Following Total Hip Arthroplasty.

NCT03347266

Phase 2 Completed 12 enrolled Vivozon, Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this phase 2 study is to evaluate the efficacy and safety of an analgesic drug candidate, VVZ-149 Injections. The study is designed as randomized, double-blind, parallel, and placebo-controlled study.

Timeline

Start
2017-12-20
Primary completion
2018-07-19
Completion
2018-07-19

Drugs

EvaluationDrugModalityDoseRoute
Subject VVZ-149 Small molecule 1000 mg Intravenous

Indications

No indication recorded.